Fighting Diseases

Is Hydroxychloroquine Safe for Autoimmune Diseases?

COVID-19 has put a therapy called hydroxychloroquine in the spotlight — and, at the same time, shrouded it in confusion.
Fighting Diseases

Engineering T Cells to Prevent Type 1 Diabetes Takes Next Step Towards Human Clinical Trial

With a newly awarded grant, BRI and Seattle Children's Research Institute are making strides towards generating an engineered T cell product that can be used in a clinical trial.
Fighting Diseases

Teaming Up with Virginia Mason for Rapid COVID-19 Research

In collaboration with Virginia Mason, BRI researchers are studying COVID-19 patient blood samples to decode the immune response to this virus, helping to inform treatments and vaccines.
Fighting Diseases

A Novel Way to Study COVID-19

When the COVID-19 pandemic started unfolding, BRI Principal Investigator Adam Lacy-Hulbert, PhD, was ready to fight it.
Fighting Diseases

How BRI is Fighting COVID-19

As the coronavirus and COVID-19 turn the world upside down, it’s an unprecedented time filled with challenges that BRI is ready for.
Fighting Diseases

New Gut Immunity Program Takes on IBD, COVID-19 and More

BRI launched a new program to study how immune responses in the gut go wrong and lead to IBD, celiac disease and other conditions.
Fighting Diseases

Another Landmark T1D Discovery

Alice Long, PhD, and her colleagues made a discovery that opens the door to potential new type 1 diabetes treatment strategies.
Fighting Diseases

A Quest to Cure Rheumatoid Arthritis

BRI researchers are on a quest to cure rheumatoid arthritis.

This blog does not  provide medical advice, nor is it a substitute
for professional medical advice, diagnosis or treatment.